Search - Centre François Baclesse Access content directly

Filter your results

32 Results
Deposit type : Notice

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi , Laura Faivre , François Lesaunier , Remy Delva , Gwenaëlle Gravis , et al.
Lancet Oncology, 2015, 16 (7), pp.787 - 794. ⟨10.1016/S1470-2045(15)00011-X⟩
Journal articles hal-01914904v1

Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study

Marleen A.E. van Der Kaaij , Natacha Heutte , Paul Meijnders , Edwige Abeilard-Lemoisson , Michele Spina , et al.
Journal of Clinical Oncology, 2012, 30 (3), pp.291-299. ⟨10.1200/JCO.2011.37.1989⟩
Journal articles hal-02358987v1

A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer

Nadine Houédé , M. Pulido , L. Mourey , F. Joly , J. M. Ferrero , et al.
Oncologist, 2014, 19, pp.1227--8. ⟨10.1634/theoncologist.2014-0345⟩
Journal articles hal-02168062v1

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Patricia Pautier , Anne Floquet , Christine Chevreau , Nicolas Penel , Cécile Guillemet , et al.
Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩
Journal articles hal-03623745v1

Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group

Axel Le Cesne , Isabelle Ray-Coquard , Florence Duffaud , Christine Chevreau , Nicolas Penel , et al.
European Journal of Cancer, 2015, 51 (6), pp.742-750. ⟨10.1016/j.ejca.2015.01.006⟩
Journal articles hal-03623749v1

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting―IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms

Michèle Beau-Faller , Hélène Blons , Caroline Domerg , Dorota Gajda , Nicolas Richard , et al.
Journal of Molecular Diagnostics, 2014, 16 (1), pp.45--55. ⟨10.1016/j.jmoldx.2013.07.009⟩
Journal articles hal-01064291v1

Interobserver agreement of qualitative analysis and tumor delineation of FMISO and FLT PET-images in lung cancer.

Sébastien Thureau , Philippe Chaumet Riffaud , Romain Modzelewski , Philippe Fernandez , Laurent Tessonnier , et al.
Journal of Nuclear Medicine, 2013, 54 (9), pp.1543-50
Journal articles hal-00937372v1

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

Valérie Bonadona , Bernard Bonaïti , Sylviane Olschwang , Sophie Grandjouan , Laetitia Huiart , et al.
Journal of the American Medical Association, 2011, 305 (22), pp.2304-2310. ⟨10.1001/jama.2011.743⟩
Journal articles hal-00780536v1

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

Antoine Italiano , Angela Cioffi , Nicolas Penel , Matteo Giaj Levra , Corinne Delcambre , et al.
Cancer, 2012, 118 (13), pp.3330-3336. ⟨10.1002/cncr.26599⟩
Journal articles hal-03623788v1

Etude Genesis : trois ans d'inclusion en France

Séverine Eon-Marchais , Morgane Marcou , Lucie Toulemonde , Marie-Gabrielle Dondon , Juana Beauvallet , et al.
EPI-CLIN - 5e Conférence Francophone d'Épidémiologie Clinique, May 2011, Marseille, France. 59 (S1), pp.S31, P5-9, 2011, Revue d'Épidémiologie et de Santé Publique. ⟨10.1016/j.respe.2011.02.050⟩
Conference poster inserm-00609695v1

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

P. Rodon , C. Hulin , B. Pegourie , M. Tiab , B. Anglaret , et al.
Haematologica, 2015, 100 (2), pp.e56-9. ⟨10.3324/haematol.2014.110890⟩
Journal articles hal-01116536v1

Descriptive epidemiology of upper aerodigestive tract cancers in France: Incidence over 1980-2005 and projection to 2010

K. Ligier , A. Belot , G. Launoy , M. Velten , Nadine Bossard , et al.
Oral Oncology, 2011, 47, pp.302-307. ⟨10.1016/j.oraloncology.2011.02.013⟩
Journal articles hal-02297712v1

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

David G Cox , Jacques Simard , Daniel Sinnett , Yosr Hamdi , Penny Soucy , et al.
Human Molecular Genetics, 2011, 20 (23), pp.4732-47. ⟨10.1093/hmg/ddr388⟩
Journal articles hal-00790211v1

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

Axel Le Cesne , Jean-Yves Blay , Julien Domont , Emmanuelle Tresch-Bruneel , Christine Chevreau , et al.
Lancet Oncology, 2015, 16 (3), pp.312-319. ⟨10.1016/s1470-2045(15)70031-8⟩
Journal articles hal-03623747v1

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.

A. Trebouet , T. Marchand , R. Lemal , Emmanuel Gyan , Florence Broussais-Guillaumot , et al.
Annals of Oncology, 2013, 24 (10), pp.2612-8. ⟨10.1093/annonc/mdt282⟩
Journal articles inserm-00869892v1

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

Francois Le Loarer , Sarah Watson , Gaëlle Pierron , Vincent Thomas de Montpreville , Stelly Ballet , et al.
Nature Genetics, 2015, 47 (10), pp.1200 - 1205. ⟨10.1038/ng.3399⟩
Journal articles hal-01684775v1

Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study

Florence Joly , Remy Delva , Loic Mourey , Emmanuel Sevin , Emmanuelle Bompas , et al.
BJU International, 2015, 115 (1), pp.65-73. ⟨10.1111/bju.12552⟩
Journal articles hal-01939743v1

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

Pierre-Yves Salaun , Loïc Campion , Claire Bournaud , Alain Faivre-Chauvet , Jean-Philippe Vuillez , et al.
Journal of Nuclear Medicine, 2012, 53 (8), pp.1185-92. ⟨10.2967/jnumed.111.101865⟩
Journal articles hal-00932253v1

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

Isabelle Ray-Coquard , Julien Domont , Emmanuelle Tresch-Bruneel , Emmanuelle Bompas , Philippe Cassier , et al.
Journal of Clinical Oncology, 2015, 33 (25), pp.2797-2802. ⟨10.1200/jco.2015.60.8505⟩
Journal articles hal-03623742v1

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

David W. Miles , Arlene Chan , Luc Y. Dirix , Javier Cortés , Xavier B. Pivot , et al.
Journal of Clinical Oncology, 2010, 28 (20), pp.3239-47. ⟨10.1200/JCO.2008.21.6457⟩
Journal articles inserm-00508083v1

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.

Nadine Houede , Philippe Beuzeboc , Sophie Gourgou , Diego Tosi , Laura Moise , et al.
Journal of Clinical Oncology, 2015, 33 (7_suppl), pp.264-264. ⟨10.1200/jco.2015.33.7_suppl.264⟩
Journal articles hal-03578471v1

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

Thierry Conroy , Marie-Pierre Galais , Jean-Luc Raoul , Olivier Bouche , Sophie Gourgou-Bourgade , et al.
Lancet Oncology, 2014, 15 (3), pp.305 - 314. ⟨10.1016/S1470-2045(14)70028-2⟩
Journal articles hal-01801252v1

Description des modalités pratiques de prescription d’un facteur de croissance de la lignée granulocytaire (G-CSF) chez les patientes recevant une chimiothérapie pour un cancer du sein : étude Opaline

William Jacot , Eric-Charles Antoine , Maya Hacini , Cathy Giron , Alain Riviere , et al.
Bulletin du Cancer, 2015, 102 (12), pp.979-992. ⟨10.1016/j.bulcan.2015.09.004⟩
Journal articles hal-02336942v1

Multiple sequence variants of BRCA2 exon 7 alter splicing regulation

Pascaline Gaildrat , Sophie E. Krieger , Daniela Di Giacomo , Julie Abdat , Françoise Révillion , et al.
Journal of Medical Genetics, 2012, 49 (10), pp.609-617. ⟨10.1136/jmedgenet-2012-100965⟩
Journal articles istex hal-02336313v1

Parenthood in Survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control Study

Marleen A.E. van Der Kaaij , Natacha Heutte , Paul Meijnders , Edwige Abeilard-Lemoisson , Michele Spina , et al.
Journal of Clinical Oncology, 2012, 30 (31), pp.3854-3863. ⟨10.1200/JCO.2011.40.8906⟩
Journal articles hal-02358978v1

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

Sébastien Couraud , Pierre-Jean Souquet , Christophe Paris , Pascal Dô , Hélène Doubre , et al.
European Respiratory Journal, 2015, 45 (5), pp.1403-1414. ⟨10.1183/09031936.00097214⟩
Journal articles hal-02456986v1

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

G. Ferron , L. Simon , F. Guyon , O. Glehen , D. Goéré , et al.
EJSO - European Journal of Surgical Oncology, 2015, 41 (10), pp.1361-1367. ⟨10.1016/j.ejso.2015.07.012⟩
Journal articles hal-02334165v1

Etude Genesis : deux ans d'inclusion !

Séverine Eon-Marchais , Morgane Marcou , Lucie Toulemonde , Marie-Gabrielle Dondon , Juana Beauvallet , et al.
5es Assises de Génétique Humaine et Médicale, Jan 2010, Strasbourg, France. 26 (HS1), p. 126-127, P302, 2010, Médecine Sciences: M/S
Conference poster inserm-00456804v1

Strategies of radioiodine ablation in patients with low-risk thyroid cancer.

Martin Schlumberger , Bogdan Catargi , Isabelle Borget , Désirée Deandreis , Slimane Zerdoud , et al.
New England Journal of Medicine, 2012, 366 (18), pp.1663-73
Journal articles hal-00942194v1

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

E. Samalin , O. Bouche , S. Thezenas , E. Francois , Antoine Adenis , et al.
Breast Cancer Research and Treatment, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Journal articles hal-02181353v1